About the Authors
- Modesto J. Remuiñán
-
* E-mail: Modesto.b.remuinan@gsk.com
Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain
- Esther Pérez-Herrán
-
Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain
- Joaquín Rullás
-
Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain
- Carlos Alemparte
-
Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain
- María Martínez-Hoyos
-
Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain
- David J. Dow
-
Affiliation Molecular and Cellular Technologies, GlaxoSmithKline, Stevenage, United Kingdom
- Johnson Afari
-
Affiliation Molecular and Cellular Technologies, GlaxoSmithKline, Stevenage, United Kingdom
- Nalini Mehta
-
Affiliation Molecular and Cellular Technologies, GlaxoSmithKline, Stevenage, United Kingdom
- Jorge Esquivias
-
Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain
- Elena Jiménez
-
Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain
- Fátima Ortega-Muro
-
Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain
- María Teresa Fraile-Gabaldón
-
Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain
- Vickey L. Spivey
-
Affiliation Molecular and Cellular Technologies, GlaxoSmithKline, Stevenage, United Kingdom
- Nicholas J. Loman
-
Affiliation School of Biosciences, University of Birmingham, Edgbaston, United Kingdom
- Mark J. Pallen
-
Affiliation School of Biosciences, University of Birmingham, Edgbaston, United Kingdom
- Chrystala Constantinidou
-
Affiliation School of Biosciences, University of Birmingham, Edgbaston, United Kingdom
- Douglas J. Minick
-
Affiliation Department of Analytical Chemistry, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America
- Mónica Cacho
-
Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain
- María José Rebollo-López
-
Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain
- Carolina González
-
Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain
- Verónica Sousa
-
Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain
- Iñigo Angulo-Barturen
-
Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain
- Alfonso Mendoza-Losana
-
Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain
- David Barros
-
Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain
- Gurdyal S. Besra
-
Affiliation School of Biosciences, University of Birmingham, Edgbaston, United Kingdom
- Lluís Ballell
-
Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain
- Nicholas Cammack
-
Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain
Competing Interests
The authors declare the following co-authors Modesto J. Remuiñán, Esther Pérez-Herrán, Joaquín Rullás, Carlos Alemparte, Maria Martinez-Hoyos, David J. Dow, Johnson Afari, Nalini Mehta, Jorge Esquivias, Elena Jiménez, Fátima Ortega-Muro, María Teresa Fraile-Gabaldón, Vickey L. Spivey, Douglas J. Minick, Mónica Cacho, María Jose Rebollo-Lopez, Carolina Gonzalez, Verónica Sousa, Iñigo Angulo- Barturen, Alfonso Mendoza-Losana, David Barros, Lluís Ballell and Nicholas Cammack are employed by GlaxoSmithKline. However, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. They also declare there is the following public patent (WO2012143522, Tetrahydropyrazolo [1,5-A] pyrimidine as anti-tuberculosis compounds, 20 April 2012) relating to material pertinent to this article. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: MJR EPH JR CA DJD EJ FOM MTFG IAB AML DB GSB LB NC. Performed the experiments: EPH JR CA MMH JA NM JE DJM MC MJRL CG VS. Analyzed the data: EPH JR JA NM FOM VLS NJL MJP CC DJM. Contributed reagents/materials/analysis tools: MC JE. Wrote the paper: MJR GSB LB.